1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSBIR/STTR Program Infographic is sponsored by National Institute of Mental Health (NIMH). Supports research and development by small businesses aligned with NIMH's strategic plan, focusing on mental health and neuroscience.
Get alerted about grants like this
Save a search for “National Institute of Mental Health (NIMH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
SBIR/STTR Program Infographic - National Institute of Mental Health (NIMH) Due to current HHS and NIH restructuring, some content on nimh. nih. gov is not being updated regularly.
Please refer to clinicaltrials. gov and nih. gov for up-to-date information on NIH research.
Opportunities & Announcements Funding Strategy for Grants Grant Writing & Approval Process SBIR/STTR Program Infographic Use this interactive chart that contains helpful information to guide you through the NIH SBIR/STTR application process. Click though the chart for answers to your related questions.
Start the SBIR/STTR Application Process infographic Confirm Your Small Business Meets Eligibility Requirements Confirm Your Small Business Concern Meets Eligibility Requirements View the eligibility requirements by visiting the SBIR/STTR eligibility criteria webpage. Develop an Innovative Research Idea Develop an Innovative Research Idea Have a ground breaking idea that can be commercialized?
HHS can provide funding for your technology idea! The Omnibus SBIR and STTR solicitations allow small businesses to propose technologies focused on health, life-science or medicine to HHS for funding consideration. Be sure to speak with an HHS SBIR/STTR program manager BEFORE submitting an application.
Program managers will discuss the Institute or Center (IC)’s interest in the proposed technology and can offer application-specific advice. Also, check to see if one of the ICs has issued a targeted SBIR/STTR solicitation about your research topic. SBIR Omnibus and STTR Omnibus Solicitations Complete Required Registrations You must complete multiple registrations prior to preparing an application and applying for funding.
All registrations must be completed prior to the application being submitted. It can take 6 weeks or more to complete the registration process.
SAM (System for Award Management) – required to do business with the U.S. government SAM will issue a 12-character unique entity identifier (UEI) used to complete your full SAM registration and which serves as the official organization identifier in other federal systems eRA Commons – required to do business with NIH and some HHS agencies Grants.
gov – required to submit grant applications through the federal-wide grant portal SBA (Small Business Administration) – required to participate in SBIR and STTR federal funding programs How to Apply - Application Guide , use the “SBIR/STTR Instructions” Follow the funding opportunity instructions “Section IV.
Application and Submission Information” contains opportunity-specific guidance not contained in the application guide Related Notices, which are listed in Part 1. Overview information Find guidance, resources for first-time applicants, and all the necessary forms in one convenient location.
Standard deadlines for the HHS SBIR/STTR Omnibus: January 5, April 5, September 5 For additional information please see our FAQs Submit Your SBIR/STTR Grant Application to NIH Electronically Submit Your SBIR/STTR Grant Application to NIH Electronically Error-free applications must be accepted by Grants. gov with a time stamp on or before 5 p. m.
local time of the submitting organization on the due date. NIH’s late policy does not allow corrections after the due date. Once the application is submitted, the signing official (SO) or PI must check for errors or warnings in eRA Commons.
Errors do STOP application processing and must be corrected. Warnings do not stop application processing and are corrected at the discretion of the applicant. Using ASSIST will help the applicant catch errors before submitting.
Once an error-free application is received by NIH from Grants. gov, the eRA system will assemble the grant application image. Applicants have two business days to view the error free assembled application image before the application automatically moves forward for further processing.
The SO can reject application within viewing window and submit a Changed/Corrected application prior to the due date.
Submit, Track, and View Your Application Use eRA Commons to Follow Application Status SBIR/STTR Selection Process and Review Criteria Submission Dates and Review Schedule NIH Center for Scientific Review Evaluates Your Grant NIH Center for Scientific Review Evaluates Your Grant on Scientific and Commercialization Potential NIH uses a rigorous dual peer review system to ensure only the most meritorious scientific proposals are funded.
For SBIR/STTR applications, a technology’s commercialization potential is also evaluated during the review process.
NIH Peer Review Policies and Practices NIH Peer Review Process Overview and Scoring Criteria NIH Center for Scientific Review Small Business Study Sections Funding Decisions and Awards are Made Funding Decisions and Awards are Made Once the applicant has gone through peer review, the Advisory Council/Board of the potential awarding Institute or Center (IC) performs the second level of review and gives advice to the IC staff and IC director.
The IC director makes the final funding decisions based on staff and Advisory Council/Board advice. Applicants must ensure that all of the Just-In-Time reporting requirements have been met, which includes the IRB approval, Federal-wide Assurance (FAW) and Human Subjects Education Training. View the NIH SBIR/STTR Just-in-Time (JIT) Procedures Module for information on how to submit all required documentation.
If the application is funded, the small business will receive a Notice of Award . If the application is not funded, the IC program officer can discuss how the application can be revised so it may be funded in the future.
Post-award Monitoring and Reporting NIH SBIR/STTR Just-in-Time (JIT) Procedures Module Awardee Conducts Research Awardee Conducts Research The awardee will need a great deal of information to be a successful steward of federal funds. The NIH Welcome Wagon Letter provides information and resources for new grantee organizations on how to manage the award.
View the NIH Grants Policy Statement for comprehensive information about the post-award processes and requirements. For specific questions, consult the appropriate NIH program officer or grants management specialist.
Proof of Concept/ Feasibility Study for 6 months to 2 years Technical and Business Assistance (TABA) program for NIH SBIR/STTR Phase I and Phase I Fast-Track awardees provides a report assessing the current state of the Phase I project toward commercialization. The report identifies strengths and weaknesses that can help the company strategize for the project’s next steps.
For more information see the Technical and Business Assistance (TABA) Needs Assessment webpage . The objective of Phase I is to establish the technical merit, feasibility, and commercial potential of the proposed R&D efforts prior to further federal support in Phase II. See Budget and Timelines for Funding for additional information.
One application for Phase I and Phase II that is submitted and reviewed together. The Congressional authority for SBIR Direct Phase II is reinstated until FY2022 . Bypass Phase I if feasibility studies are completed.
Full R&D for 1 to 3 Years For Phase II or IIB Awardees Technical and Business Assistance (TABA) program to help NIH SBIR/STTR Phase II/IIB awardees in one of the following areas: For more information see the TABA Consulting Services webpage . The objective of Phase II is to continue the R&D efforts initiated in Phase I.
Funding is based on the results achieved in Phase I and the scientific and technical merit and commercial potential of the project proposed in Phase II. See Budget and Timelines for Funding for additional information. $1M Per Year for Up to 3 Years - Must Have Initial Phase II to Apply Some NIH ICs offer Phase IIB awards for projects that require extraordinary time and effort in the R&D phase.
These awards normally do not exceed $1,000,000 per year for up to 3 years. Talk to your IC program officer if your small business is interested in a Phase IIB award. Commercialization Readiness Program (CRP) SBIR or STTR-supported projects may benefit from funding and support above and beyond the Phase II or Phase IIB awards.
The CRP Program provides additional technical assistance and late-stage research and development support not typically covered within small business awards to help products get to market. Commercialization - Non-SBIR/STTR Funds The objective of Phase III is for the small business to pursue commercialization objectives resulting from the Phase I/II/IIB R&D activities. The NIH SBIR program does not fund Phase III.
Based on current listing details, eligibility includes: Small businesses specializing in mental health and neuroscience research. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.